Uricases: reflections on recent developments in the management of challenging gout patients
Oral urate-lowering therapy (ULT) is key to treating gout. However, many patients receiving oral ULT do not achieve the target serum urate (SU) levels, partly because some patients cannot tolerate or have contraindications to their use, mainly due to comorbidities. This may lead to uncontrolled gout...
Saved in:
| Main Authors: | Naomi Schlesinger, Dan Kaufmann |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Open Exploration Publishing Inc.
2024-10-01
|
| Series: | Exploration of Musculoskeletal Diseases |
| Subjects: | |
| Online Access: | https://www.explorationpub.com/uploads/Article/A100770/100770.pdf |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Uricase-Expressing Engineered Macrophages Alleviate Murine Hyperuricemia
by: Yu-Zhong Feng, et al.
Published: (2024-11-01) -
Streptomyces griseorubens as a microbial cell factory for extracellular uricase production and bioprocess optimization using statistical approach
by: Noura El-Ahmady El-Naggar, et al.
Published: (2024-11-01) -
Characterization of a thermostable uricase derived from Thermoactinospora rubra YIM 77501T and its heat-resistant mechanism
by: Xin Yan, et al.
Published: (2025-06-01) -
Stability and functional consequences of disulfide bond engineering in Aspergillus flavus uricase
by: Mohammad Reza Rahbar, et al.
Published: (2025-05-01) -
Characteristics and Management of Uncontrolled Gout Prior to Pegloticase Therapy: A 2-year Claims Analysis
by: Robert J. Morlock, et al.
Published: (2024-11-01)